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SUMMARY
NLR genes mediate host immunity to various pathogenic stimuli. However, in vivo evidence for NLR
involvement in viral sensing has not been widely investigated and remains controversial. As an
ultimate test of the physiologic role of NLRP3 during RNA viral infection, this work explores the
in vivo role of NLRP3 inflammasome components during influenza virus infection. Mice lacking
Nlrp3, ASC, or Caspase-1, but not Nlrc4, exhibit dramatically increased mortality but reduced
immune response following influenza virus exposure. Utilizing analogs of dsRNA (poly(I:C)) and
ssRNA (ssRNA40), we demonstrate that NLRP3-mediated response can be activated by RNA
species. Mechanistically, NLRP3 inflammasome activation by influenza virus is dependent upon
lysosomal maturation and reactive oxygen species. Inhibition of ROS induction eliminated IL-1β
production in animals during influenza infection. Together, these data place the NLRP3
inflammasome as an essential component in host defense against influenza infection through the
sensing of viral RNA.
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INTRODUCTON
Innate immune responses to influenza and other pathogens typically involve a highly conserved
host-cell signaling mechanism designed to protect and rid the host of harmful microbes.
Recognition of conserved microbial structures, known as pathogen-associated molecular
patterns (PAMPs), within cells of a myeloid origin is a hallmark feature of adequate host
immunity. PAMPs are recognized by pattern recognition receptors or sensors (PRRs) which
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subsequently initiate signaling cascades resulting in the production of proinflammatory
cytokines and type-I interferons. Thus far, three families of PRRs have been identified and
shown to be activated in response to viral pathogens, including the RLHs (RIG-I-like
helicases), TLRs (toll-like receptors) and NLRs (nucleotide binding domain and leucine-rich-
repeat-containing)(Akira et al., 2006; Ting et al., 2008). The individual members of these
families can be distinguished by ligand specificity, cellular localization and activation of
unique downstream signaling pathways. The strategy of employing multiple families of PRRs
affords the host a high degree of functional redundancy and provides multiple mechanisms to
optimally respond to a diverse range of pathogens (Kawai and Akira, 2007).
The NLR proteins are emerging as a major route by which the innate immune system responds
to microbial pathogens. Substantial evidence suggests that the NLR proteins serve as
intracellular mediators of PAMP initiated host-cell signaling, although the exact mechanisms
underlying NLR responses to pathogens are not completely understood. One of the
fundamental reactions of the innate immune response to viral infection is the processing and
release of proinflammatory cytokines, including the regulation and release of IL-1β. It has been
demonstrated that the NLR protein, NLRP3, together with its adapter protein, Apoptotic Speck
protein containing a CARD (ASC), regulate IL-1β maturation through the formation of a
biochemical complex called the inflammasome (Agostini et al., 2004). This inflammasome
regulates the activation of caspase-1 and subsequent cleavage of the IL-1β and IL-18 precursor
into their functional form, which is then released from the cell. In addition to NLRP3, other
NLRs such as NLRC4 and NLRP1 also cause caspase-1 activation and IL-1β production
(Mariathasan and Monack, 2007).
Although the function of the NLRP3 inflammasome in mediating responses to bacterial
pathogens have been studied by several groups, the in vivo function of this important signaling
complex during the course of viral infection is not well understood. In vitro transfection of
DNA from viruses, bacteria or mammalian sources into macrophages activates the NLRP3
inflammasome, but this result would suggest a more global response to DNA rather than an
antiviral response (Muruve et al., 2008). One report has shown that a synthetic analog of
dsRNA, poly(I:C), activates IL-1β through the NLRP3 pathway (Kanneganti et al., 2006).
However, another group failed to replicate this finding (Muruve et al., 2008). Thus, the role of
NLRP3 and the inflammasome during viral infection remains unresolved. Equally significant,
the majority of NLR characterization has been based on in vitro/ex vivo data generated from
human cell lines and primary mouse cells. While these studies have provided a wealth of
information, the underlying relevance of these proteins in actual pathogenesis and host defense
against pathogens in vivo has been much less defined.
To assess the contribution of NLR inflammasomes in viral pathogenesis, we assessed the host
response to the influenza A virus. Influenza infection results in a highly contagious respiratory
illness leading to significant morbidity and occasionally death. Annual epidemics typically
affect 5–15% of the population and are thought to result in 250,000 to 500,000 deaths annually.
Of the three types of influenza viruses, influenza A viruses are the most virulent type to humans
and are capable of infecting multiple mammalian and avian species. Human influenza A viruses
can be further divided into different serotypes based on the antibody response to the viral
surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). The influenza A virus
genome is composed of 8 individual strands of ssRNA, which encode a total of 11 different
proteins.
In this report, we show that the NLRP3 inflammasome has a profound influence on in vivo
host immune response and survival following airway infection with a mouse-adapted influenza
A virus. Utilizing in vivo challenges with a synthetic analog of dsRNA, we demonstrate a
possible mechanism underlying the NLRP3 associated innate immune response to viruses
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involves the recognition of viral RNA. Furthermore, we extend the relevancy of these findings
to human cells by establishing that ssRNA, dsRNA and influenza A virus-mediated IL-1β
release by human monocytes is dependent on the NLRP3 inflammasome and rely on intact
lysosomal function, lysosomal enzymes such as cathepsin B, and reactive oxygen species
(ROS). This report is the first to demonstrate that the NLRP3 inflammasome is an essential
component of the in vivo host immune response to viral infection in a model system that is
physiologically relevant to human disease.
RESULTS
Loss of NLR inflammasome activity, but not MyD88, alters mouse survival and inflammation
in response to influenza virus infection
To assess the in vivo physiological contribution of NLR and TLR signaling pathways in
response to influenza virus infection, we utilized gene deletion mice in an influenza A/PR/8/34
virus infection model. Previous studies utilizing mouse primary macrophages have
demonstrated that NLR components are necessary for IL-1β release in response to influenza
virus infection in culture (Kanneganti et al., 2006). However, the in vivo physiological
relevance of these findings has yet to be explored extensively. To assess the contribution of
NLR inflammasomes in mouse survival and inflammation, we assessed mice deficient in either
the NLR adaptor protein ASC or caspase-1. Mice lacking these inflammasome components
show significantly increased mortality following influenza infection (Figure 1A). As a
comparison and as a control, we included the MyD88−/− mice. Previous studies have
demonstrated that TLR3, 7, 8 and 9 represent the subset of TLRs which recognize viral nucleic
acids and mediate the induction of type-I IFN (Kawai and Akira, 2007; Koyama et al., 2007).
TLR7, 8 and 9 are dependent upon the TLR adaptor protein MyD88 for proper signal
transduction. However, mouse survival was only moderately decreased for MyD88−/− animals,
suggesting that removal of MyD88 and the disruption of the associated TLR7/8/9 signaling
cascades only modestly affect mouse survival (Figure 1B).
To assess the extent of inflammation, mice were sacrificed 3 days post-inoculation (dpi.) and
the lungs were harvested for histology (Figure 1C–F). We observed a significant increase in
airway inflammation, characterized by enhanced macrophage and neutrophil influx into the
airways, 3 dpi. in wild type (D) and MyD88−/− (E) mice as compared to the mock inoculated
wild type (C). In contrast, the infected ASC−/− (Figure 1F) and caspase-1−/− (not shown) mice
demonstrated significantly reduced airway inflammation. Histology scoring, by blinded
reviewer, confirmed the significant attenuation of airway inflammation in the ASC−/− mice
(Figure 1G).
The Nlrp3 inflammasome is required for mouse survival and inflammation following influenza
virus infection
The above data suggests that proper activation of an NLR inflammasome is necessary for host
survival and for mediating the innate immune response following influenza virus infection. It
is well established that the NLR protein, NLRP3, can form an inflammasome complex with
ASC and caspase-1 in response to a plethora of stimuli (Eisenbarth et al., 2008; Li et al.,
2008; Martinon et al., 2006; Sutterwala et al., 2006). In addition to NLRP3, other NLRs such
as NLRC4 have been suggested to form an NLRP3 independent inflammasome which
functions in IL-1β maturation in response to Salmonella typhimurium and
Pseudomonasaeruginosa infection (Mariathasan et al., 2004; Miao et al., 2008). Following
influenza inoculation, all animals demonstrated a decrease in body weight (Supplemental
Figure S1). However, as seen in Figure 2A, a dramatic decrease in survival was observed in
Nlrp3−/− mice following virus infection, with no differences observed in mortality between
Nlrc4−/− and wild type mice. Interestingly, the removal of Nlrp3 produced a more dramatic
Allen et al. Page 3













effect on animal survival than the removal of ASC or caspase-1, suggesting the possibility that
Nlrp3 might exert biologic effects in addition to caspase-1 activation; however, this remains
to be explored.
As observed with the ASC−/− animals, Nlrp3−/− mice show a significant decrease in airway
inflammation following influenza infection. Histology scoring revealed no increase in
inflammation in mock infected animals and only a modest increase was observed in the
Nlrp3−/− mice while a significant increase in airway inflammation was observed in the
Nlrc4−/− and wild type animals (Figure 2B). Compared to mock infected mice (C),
histopathology assessments revealed a mild increase in airway inflammation in virus-infected
Nlrp3−/− mice (D), but an exacerbated increase in Nlrc4−/−(E) and wild type (F) animals 3 dpi.
(Figure 2C–F). To further characterize the composition of the cell populations infiltrating the
airways during viral infection, bronchoalveolar lavage fluid (BALF) was harvested and
cellularity was assessed. Consistent with the histology findings, Nlrp3−/− animals demonstrate
a significant decrease in total BALF cellularity compared to either the Nlrc4−/− or wild type
animals (Figure 2G). Analysis of BALF cellularity indicates that macrophages and neutrophils
represent the bulk of infiltrating cells in response to influenza. Differential profiling revealed
no significant differences in the percent cellular composition of the BALF between genotypes
(Figure 2H); however, the Nlrp3−/− mice demonstrated an overall decrease in the number of
monocytes and granulocytes (Figure 2I). Together, this indicates that the Nlrp3 inflammasome
is an essential mediator of in vivo inflammatory responses to influenza virus.
We have observed that Nlrp3−/− animals show reduced immune responses following influenza
challenge. To determine if this reduction resulted in a defect in viral clearance, lungs from wild
type and Nlrp3−/− mice were harvested 3 and 7 dpi. During the early stages of infection (3
dpi.), all influenza challenged mice demonstrated an increase in viral titer and no difference
was observed between wild type and Nlrp3−/− mice (Figure 2J). However, by 7 dpi. the
Nlrp3−/− mice demonstrated approximately 2-fold higher viral titer levels in the lungs
compared to the wild type animals (Figure 2J), providing evidence for a defect in viral clearance
in the absence of Nlrp3.
Components of the Nlrp3 inflammasome are highly expressed in myeloid cells and the lungs
during influenza virus infection
To assess the relevance of Nlrp3 and ASC in a panel of mouse cells, we assayed expression
by quantitative rtPCR in primary myeloid, lymphoid and airway epithelial cells (Thompson et
al., 2006; Willingham et al., 2007). Under naïve conditions, both Nlrp3 and ASC genes are
highly expressed in primary macrophages, with nominal levels detected in T and B
lymphocytes (Figure 3A and B). In the mouse airway epithelial cells (MAEC), only a low level
of ASC was detected and Nlrp3 was not found (Figure 3A and B).
To characterize the effects of viral infection on gene transcription in these differentiated cell
types, bone marrow derived macrophages (BMΦ) and MAECs were challenged with influenza
A/PR/8/34. No significant change in either Nlrp3 or Nlrc4 transcription was observed
following viral challenge in the BMΦs; however, a significant increase in Il-1β mRNA level
was detected (Figure 3C). Under naïve conditions, Nlrp3 was not detected in the MAECs.
Following influenza infection, a modest increase in Nlrp3 transcription was observed, while
no significant changes were found in Nlrc4 and Il-1β transcription (Figure 3D).
It should be noted that ex vivo cultured mouse BMΦs were refractory to influenza virus
infection as shown by the precipitous drop in viral titer following exposure (Supplemental
Figure S2A). Due to the lack of a productive infection, we often observed inconsistent IL-1β
cytokine levels at the MOIs used in this study. For this reason, we did not pursue additional
experiments using primary mouse macrophages. Even though IL-1β levels were inconsistent,
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at MOIs greater than 10 we were able to observe an increase in IFN-β at 12 hours, with no
differences observed between the genotypes (Supplemental Figure S2B) indicating that the
genes studied did not affect IFN-β production.
To further assess the contribution of the NLRP3 inflammasome in vivo, we sought to assess
changes in mRNA expression levels of inflammasome components and IL-1β over a time
course of influenza virus infection. Total lung RNA was extracted from tissue homogenates
and gene expression was assessed for Nlrp3, ASC, Il-1β and Caspase-1 (Casp1) (Figure 3E).
A significant increase in gene transcription was observed 3 dpi. for all 4 assessed genes. This
was followed by a significant reduction of all genes except caspase-1 by day 7 (Figure 3E).
These results indicate that influenza induced a substantial increase in all components of the
Nlrp3 inflammasome in the lungs and infiltrating cells of inoculated animals 3 dpi. and indicate
a profound effect of viral infection on the inflammasome genes leading to their biologic
function.
To further determine the in vivo contribution of the macrophages in the lungs of mice following
virus infection, lungs were harvested 3 dpi. and cells containing viral antigen were visualized
by IHC/confocal microscopy. The primary cells targeted in vivo in the mouse are the airway
epithelial cells (Supplemental Figure 3A–C), with 15% of macrophages being the second
largest population (Supplemental Figure 3D–F). However a majority of macrophages and other
leukocytes present in the lungs of infected mice were IHC negative (Supplemental Figure 3G–
I). Significantly smaller populations of polymorphonuclear cells and alveolar epithelial cells
(<1%) were also infected with virus (not shown).
NLRP3 inflammasome components are required for the production of proinflammatory
cytokines and chemokines during influenza virus infection
The above experiments indicate Nlrp3−/− and ASC−/− mice demonstrate attenuated airway
inflammation and reduced survival following influenza virus infection. We next sought to
assess changes in serum and BALF cytokines known to play roles in host immune responses
to virus. A significant increase in IL-1β was detected in the serum and BALF from wild type
animals. This increase was dependent on Nlrp3 and ASC, but independent of Nlrc4 (Figure
4A and C). To demonstrate that this lack of IL-1β is due to reduced post-translational processing
by the Nlrp3 inflammasome, we assessed lung transcription of Il-1β and observed significant
increases in Il-1β transcription in all mouse lines regardless of genotype (Supplemental Figure
4). As previously mentioned, IL-18 has also been shown to be a critical mediator of influenza
infection and its maturation is also reliant on NLR inflammasome activation. A significant
increase in serum IL-18 was detected in the wild type mice (Figure 4B). However, as with
IL-1β, IL-18 was significantly reduced to mock-infected levels in mice lacking either Nlrp3
or ASC (Figure 4B). As with IL-1β, KC, MIP2α, TNFα, IL-6, IFNγ and IL-12 facilitate a wide
spectrum of immunologic functions during respiratory virus infection. To evaluate these
cytokine levels in the lungs, we assessed the BALF supernatant by ELISA. A significant
decrease in MIP2α was also observed in the Nlrp3−/− and ASC−/− animals when compared to
wild type levels (Figure 4D), which correlates with the decreased cellularity observed in the
BALF (Figure 2I). Nlrp3−/− mice also show a modest decrease in KC (Fig. 4E). ASC−/− mice
demonstrated a statistically significant decrease in TNFα, which was not observed in the
Nlrp3−/− animals (Figure 4F). The observed attenuation in TNFα in the ASC−/− animals is
observed in other assays and may reflect a previously-reported inflammasome independent
role for ASC in the control of TNFα (Taxman et al., 2006b). No significant differences were
observed in IL-6, IFNγ or IL-12p40 following influenza infection among the different mouse
strains (Figures 4G–I). Due to the increased level of mortality observed in the Nlrp3−/− mice,
a subset of moribund animals were harvested 7 dpi. BALF IL-6 levels were significantly
elevated in the Nlrp3−/− mice compared to the levels observed in the wild type animals (Figure
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4J). While unexpected, this observation is consistent with clinical findings in humans where
influenza-infected individuals show increased IL-6 that is associated with increased morbidity
(Lee et al., 2007).
Human NLRP3 inflammasome activation in response to influenza virus is dependent upon
lysosomal maturation and ROS production
For clinical relevance, the above study of mice required verification in human cells. Airway
epithelial cells are the predominant cell type infected by influenza and previous studies have
demonstrated that these cells contribute to innate immune responses (Kato and Schleimer,
2007). Primary human airway epithelial cell cultures (HAE) (Figure 5A) were infected with
the human influenza virus A/Victoria/3/75 (H3N2) and the supernatant was harvested from
either the apical or basolateral layer as previously described (Thompson et al., 2006). Following
infection, we observed robust viral replication in the HAE cultures (Figure 5B) and increased
IL-1β levels were detected in supernatant from the apical (Figure 5C) but not the basolateral
layer. To expand upon these findings, we infected a human nasal airway epithelial cell line,
JME, and observed increased NLRP3 and ASC expression (Figure 5D) and increased IL-1β
release (Figure 5E). In addition to the JME cell lines, A/Victoria also induced a dramatic
increase in IL-1β in a human monocytic cell line (THP-1) (Figure 5F). These data indicate that
human cells of both monocytic and epithelial origin are contributors of IL-1β during influenza
virus infection
To verify that influenza virus mediated IL-1β production in THP-1s is dependent upon NLRP3
inflammasome components, we utilized small heteroduplex RNA (shRNA) knockdown to
assess the contribution of NLRP3 and ASC. An shRNA against the third putative
inflammasome component, TUCAN/CARDINAL, was also targeted by shRNA. Successful
RNA reduction is shown in Supplemental Figure S5A–C. These cells were challenged with A/
Victoria/3/75 and cell free supernatants were collected over a 24 hr time-course. No differences
in viral titer were detected between the different knockdown and wild type cell lines, 24 hrs
p.i.(Supplemental Figure S5D). When cytokine was measured, a significant increase in
IL-1β was observed in the wild type THP-1 cells and cells transfected with a scrambled shRNA
targeting sequence (shmut), 24 hrs p.i. and this increase was significantly attenuated in cells
containing shRNA targeting ASC and NLRP3, but not shRNA targeting TUCAN (Figure 5G;
Supplemental Figure S5E). The role of TUCAN, a gene found in human but not mouse, has
not been previously studied by gene reduction. This data suggest that TUCAN may not be
important for NLRP3 inflammasome function induced by influenza virus. To confirm the
specificity of shNLRP3 in IL-1β production, we also assessed TNFα release following
influenza infection. As seen in Supplemental Figure S5F, levels of TNFα were not reduced in
cell lines with shNLRP3 but modestly reduced in cells with shASC, consistent with the mouse
data described earlier. Finally we demonstrate that ZVAD-CHO, a caspase inhibitor and
YVAD-CHO, a specific peptide inhibitor of caspase-1, both attenuated IL-1β levels in a dose-
dependent fashion following influenza virus infection (Figure 5H and I).
To further explore the mechanism underlying IL-1β release in response to influenza infection,
we used pharmacological antagonist to block specific signaling pathways. Lysosomal
degradation of particulate danger-associated molecular patterns (DAMPs) has been shown to
activate the NRLP3 inflammasome (Hornung et al., 2008), however this has not been assessed
in the context of viral infection. To test this, we utilized bafilomycin A to block lysosomal
acidification via inhibition of the vacuolar H+ ATPase system. The addition of bafilomycin A
at concentrations used previously to inhibit DAMP signaling (Hornung et al., 2008) completely
abolished influenza induced IL-1β release (Figure 5J), which suggests a critical role for
lysosomes in virus-mediated NLRP3 inflammasome function. A specific lysosomal cysteine
proteinase, cathepsin B, has been associated with NLRP3-mediated cell death and IL-1β in
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response to non-viral signals (Willingham, 2008; Hornung et al., 2008). Utilizing the cathepsin
B specific inhibitor, Ca-074-Me, we observed a significant attenuation in IL-1β release
following influenza challenge (Figure 5K). This suggests the importance of cathepsin B in
NLRP3-mediated response to influenza virus, but also suggests the involvement of additional
lysosomal processes. This decrease was not observed with specific inhibitors for cathepsin K
(Figure 5K). The release of lysosomal products into the cytosol has been demonstrated to
promote the generation of ROS and recent data have suggested that ROS generation by
asbestos, MSU and ATP is a necessary step in inflammasome activation (Dosert et al., 2008).
To test if this occurs during influenza virus infection, we treated THP-1 cells with the ROS
inhibitors N-acetyl-L-cysteine (NAc) or (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate
(APDC) (Dosert et al., 2008). Our data demonstrate attenuated IL-1β production from cells
treated with either ROS inhibitor (Figure 5L), suggesting that ROS also contributes to NLRP3
inflammasome activation in response to influenza.
Influenza infection in vivo results in a significant increase in ROS productionin the airways of
humans and mice. To assess the physiological relevance of the in vitro ROS inhibitor findings,
mice were treated with the ROS inhibitor NAc via i.n. administration as previously described
(Springer et al., 2007). Similar to the monocyte cell line findings, treatment with NAc
completely inhibited the generation of IL-1β in the BALF following influenza infection (Figure
5M). In addition to NAc, bafilomycin A and CA-074-ME were also assessed; however, the
pharmacokinetics for each of these compounds were not optimized for our in vivo assessments
(data not shown). Collectively these data suggest that NLRP3 inflammasome activation in
response to virus is mediated by sensing alterations of lysosomal content and ROS induction
in the cytosol following virus infection, utilizing pathways similar to those caused by DAMPs.
Nlrp3/NLRP3 mediates airway inflammation and IL-1β induction by the viral RNA analogs
poly(I:C) and ssRNA40
The data presented thus far demonstrate that Nlrp3 mediates in vivo airway inflammation in
response to influenza virus infection in mice and inflammasome formation in both mice and
humans. To further explore the mechanism underlying NLRP3 activation, we examine the in
vivo immune response to the viral RNA analog, poly(I:C). To assess if poly(I:C) is important
for pulmonary inflammasome activation, mice were challenged i.n. with poly(I:C) and the
resultant airway inflammation was characterized. Poly(I:C) induced moderate airway
inflammation in the wild type mice, which was significantly reduced in the Nlrp3−/− animals
(Figure 6A– B ). Nlrp3−/− mice exposed to poly(I:C) showed a significant reduction in the
overall level of airway inflammation (Figure 6C) and BALF IL-1β level (Figure 6D).
To verify this result in human cells, we utilized the shRNA knockdown cell lines described
above and demonstrate thatpoly(I:C) induced IL-1 β is dependent on ASC and NLRP3 (Figure
6E). To confirm the role of caspase-1 in this mechanism, cells were exposed to the caspase-1
inhibitor yVAD-CHO, which significantly attenuated poly(I:C) mediated IL-1β release (Figure
6F). To determine if the resultant NLRP3 and ASC dependent IL-1β release was unique to
poly(I:C), cells were also stimulated with single-stranded GU-rich RNA (ssRNA40)
complexed with the cationic lipid LyoVec to facilitate uptake. A significant NLRP3- and ASC-
dependent increase in IL-1β release was observed following ssRNA40 stimulation indicating
that NLRP3 and ASC mediate responses to ssRNA molecules (Figure 6G). To explore the
intracellular pathways that lead to NLRP3 activation by RNA analogs, we utilized
pharmacological inhibitors as described earlier and show that inflammasome activation in
response to poly(I:C) requires lysosomal maturation, cathepsin B and the generation of ROS
(Figure 6H–J).
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In this report, we assess the in vivo contribution of NLRP3 to host immune responses to viral
infection. NLRP3 forms a multi-protein inflammasome complex, which activates caspase-1
and leads to the maturation of several key proinflammatory cytokines, such as IL-1β and IL-18.
It has been established that NLRP3 responds to both microbial-associated molecules and
damage-associated molecular patterns (DAMPS) such as uric acid, alum salt and silica (Dostert
et al., 2008; Eisenbarth et al., 2008; Hornung et al., 2008; Li et al., 2008; Martinon et al.,
2006). In all of these cases, it is clear that NLRP3 promotes inflammation. A key issue is
whether NLRP3 plays a beneficial or pathogenic role. In this study, we clearly demonstrate
that NLRP3 and other components of the NLRP3 inflammasome plays a beneficial role in the
in vivo innate immune response to influenza infection and is required for normal host immune
responses to virus. An examination of the mechanism by which NLRP3 mediates host response
to RNA virus demonstrates that recognition of RNA analogs or RNA molecules are capable
of mediating these responses. A further exploration of the mechanism shows that similar to the
activation of NLRP3 by DAMPs such as particulate alum, MSU crystals and silica, activation
of the NLRP3 pathway by influenza virus, and more specifically by RNA analog, is dependent
on an intact lysosomal pathway and functional lysosomal enzymes such as cathepsin B, and is
also reliant on ROS both in vitro and in vivo. This supports the hypothesis that NLRP3 is
activated through common intracellular changes caused by either PAMPs or DAMPs, rather
than a model that evokes the direct interaction of NLRP3 with ligands of diverse molecular
structures.
The recognition of viral pathogens by cells of the innate immune system is essential for the
initiation of an ensuing inflammatory response. The endosomal TLRs TLR3, TLR7 and TLR8,
and cytoplasmic RIG-I and MDA-5 are receptors of viral PAMPs and the primary route for
the elicitation of host immune responses to virus through the regulation of type-I interferons.
Among the NLR family, there are few reports linking these proteins to the viral host response
or viral pathogenesis. One report identifies endogenous NLRX1, as an inhibitor of the RIG-I/
MDA-5 pathway through interactions with the essential mitochondrial antiviral signaling
adaptor (MAVS)(Moore et al., 2008). However, the in vivo importance of NLRX1 remains to
be determined. The involvement of NLRP3 in the macrophage response to RNA viruses has
been controversial. One study has demonstrated the importance of Nlrp3 during viral infection
in culture (Kanneganti et al., 2006) while another group was unable to confirm inflammasome
activation after poly(I:C) challenge or infection with the RNA viruses reovirus and vesicular
stomatitis virus in culture. While we did not assess reovirus or VSV, our human monocytic
cell line and in vivo mouse data clearly show that NLRP3 and ASC are indeed required for
IL-1β maturation in response to influenza virus infection as well as to dsRNA analog and
ssRNA. Therefore, our data support the first report. However, we have difficulty studying
influenza viral infection of mouse macrophages ex vivo, due to a failure to establish a productive
infection (Figure S2A). Thus, we have not precisely duplicated the ex vivo data observed by
the first report. A possible explanation to reconcile the apparent discrepancies in the field is
that different NLRs may mediate responses to different RNA viruses. The precedence for this
is provided by MDA5 and RIG-I which recognize different types of dsRNA and show viral
specificity. RIG-I responds to RNA viruses including paramyxoviruses and influenza virus,
whereas MDA5 is essential for picornavirus recognition (Kato et al., 2008; Kato et al., 2006).
Thus, it is possible that NLRP3 is responsible for dsRNA, ssRNA, DNA, Sendai virus and
influenza virus recognition and an unidentified NLR may be activated by reovirus and VSV.
Infection of mice with influenza virus results in a dramatic increase in morbidity and mortality
that mimics many of the pathophysiological aspects of the human disease. The current study
shows that ASC and Nlrp3 deficiencies reduce inflammation in the lung, and this reduced
inflammation is correlated with increased mortality and a viral clearance defect. Thus, the
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Nlrp3 inflammasome driven antiviral response is beneficial to the host following influenza
infection. While the precise role for both IL-1β and IL-18 in the immune response against viral
pathogens remains elusive, in vivo assessments of IL-1R1 and IL-18 deficient mice have shown
that these animals have reduced acute airway inflammation associated with influenza virus
infection and both have significantly decreased survival (Schmitz et al., 2005). These results
are in agreement with our findings. Our data also highlight the observation that host response
to influenza virus is specific, and requires NLRP3, but not NLRC4.
While our in vivo study shows that influenza virus is found in both airway epithelial cells and
macrophages in the mouse, only mouse macrophages express detectable Nlrp3 transcript, and
are thus the likely cell type mediating the beneficial functions of host protection by Nlrp3.
However in humans, we find NLRP3 expression in both airway epithelial cells and
macrophages and provide further evidence that NLRP3 and ASC mediate inflammatory
cytokine release in cells of human origin. Thus, NLRP3 and ASC may play an even more
profound role in host inflammation and protection upon influenza infection of humans.
Considering the disastrous nature of a possible influenza pandemic, our study suggests that
targeting the NLRP3 inflammasome for enhanced function could become an important
therapeutic measure against such an infection.
EXPERIMENTAL PROCEDURES
Experimental Animals
All studies were conducted in accordance with the NIH Guide for the Care and Use of
Laboratory Animals and the IACUC guidelines of UNC Chapel Hill. The generation of mice
lacking functional Nlrp3 (Cryopyrin/Cias1), Nlrc4 (ICE-Protease Activating Factor/Ipaf),
Apoptotic Speck protein containing a Card (ASC), Caspase-1 (Casp1) and MyD88 (Myd88)
has been previously described (Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al.,
2006).
Virus Propagation
Influenza virus A/PR/8/34 (H1N1) was propagated in the allantoic cavity of 10-day-old
embryonated specific pathogen free chicken eggs and was mouse adapted by a minimum of 6
serial passages through mice as previously described (Cottey et al., 2001). The influenza virus
A/Victoria/3/75 (H3N2) is a recombinant virus generated from cloned cDNA in 293T cells
and propagated in MDCK cells. Viral titers were determined by standard plaque assay on
confluent monolayers of MDCK cells.
Influenza Virus Infection of Human Primary Cells and Cell Lines
Cells were challenged with A/Victoria (MOI=1) for 2 hrs at 37°C. Following incubation,
supernatant was replaced with fresh media and cells were incubated at 37°C. Cell free
supernatants were harvested at select time points for viral titer and cytokine analysis. To assess
viral PAMPs, cells were incubated for 24 hrs in the presence of naked poly(I:C) (10μg)(Sigma)
or ssRNA40 complexed with LyoVec (InvivoGen) (10μg). For pharmacological assessments,
cells were treated with bafilomycin D (100–250nM), Ac-ZVAD-CHO (10–100μM), Ac-
ZVAD-CHO (10–100μM), Ca-074-Me (10–50μM), Cathepsin K Inhibitor I (10–50μM), N-
acetyl-L-cysteine (NAC) (50–100μM) or (2R, 4R)-4-aminopyrrolidine-2-4-dicarboxylate
(APDC) (50–100μM) as previously described (Dostert et al., 2008; Hornung et al., 2008;
Willingham et al., 2007).
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In vivo Influenza A Virus Infection and poly(I:C) Challenge
Animals were anesthetized and challenged by intranasal (i.n.) administration of 6×104 PFU/
ml of influenza virus A/PR/8/34 in 50μl of PBS and 0.1% Alum (Sigma). Mice were observed
and weight was assessed daily for up to 14 dpi. To assess poly(I:C) in vivo, wild type and
NLRP3−/− mice received 2 doses (50μg/dose) of poly(I:C) in 50μl of PBS and 0.1% Alum or
vehicle on alternating days and harvested 24 hrs after the second administration. To assess in
vivo ROS production, mice were treated with the ROS inhibitor NAc (250mg/kg) via i.n.
administration (as previously described by Springer et al., 2007) throughout the course of virus
challenge.
Influenza inoculated mice were euthanized either 3 or 7 dpi., and serum was collected following
cardiac puncture. Total cytokine levels were determined by ELISA (R&D Biosystems or BD
Biosciences). In some cases, Bronchoalveolar Lavage (BAL) was performed and the number
of cells present in the BAL fluid (BALF) was determined using a hemacytometer. A
morphology based differential cell count was conducted on a cytospin prep from the BALF
and stained with Diff-Quik solution (Sigma). BALF cellularity was also determined via FACS
using standard techniques and antibodies reactive to CD11b, CD11c, GR-1, B220 and CD4/
CD8. The remaining BALF was centrifuged to remove cells, and cytokine levels in the
supernatant were determined.
For histopathologic examination, lungs were fixed by inflation and immersion in 10% buffered
formalin. To evaluate airway inflammation, fixed lung slices were subjected to hematoxylin
and eosin (H&E) staining. Lung sections were scored (0 (none) – 3 (extreme)) based on
assessments of mononuclear and polymorphonuclear cell infiltration, perivascular and
peribronchiolar cuffing, and estimates of the percent of lung involved with the inflammation,
while blinded to genotype and treatment.
To assess viral titer, whole lungs were removed weighed and homogenized in PBS. Lung viral
titers were determined in the supernatants as described above.
Statistical Analysis
Data are presented as the mean +/− standard error of the mean (SEM). Analysis Of Variance
(ANOVA) followed by Tukey-Kramer HSD for multiple comparisons was performed on
complex data sets. Statistical significance for single data points was assessed by the Student’s
two-tailed t-test. Survival curves were generated utilizing the product limit method of Kaplan
and Meier and comparisons were made using the log rank test. In all cases, a p-value of less
than 0.05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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BALF bronchoalveolar lavage fluid
i.n intranasal
IL interleukin
NLR nucleotide binding domain and leucine-rich-repeat-containing
TLR Toll-like Receptor
PFU plaque forming unit
ASC Apoptotic Speck protein containing a CARD
ssRNA single stranded RNA
dsRNA double stranded RNA
poly(I:C) polyinosinic:polycytidylic acid
MOI Multiplicity of Infection
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Figure 1. Characterization of influenza virus A/PR/8/34 pathogenicity and immune response in
mice deficient in inflammasome signaling pathways
Wild type, MyD88−/−, ASC−/−and Caspase-1 (Casp1−/−) deficient mice were challenged
intranasally (i.n.) with influenza A/PR/8/34 and survival was monitored 14 dpi. (A) ASC−/−
and Casp1−/− mice demonstrated significantly increased mortality compared to the wild type
animals (*p<0.05; log rank), while (B) MyD88−/− mice demonstrated modestly increased
mortality. Mock-inoculated (n=7); influenza-infected wild type (n=19); MyD88−/− (n=11);
ASC−/− (n=12); and Casp1−/− (n=7). (C–F) Lungs were harvested 3 dpi. from wild type,
ASC−/−, Myd88−/− and mock-infected mice. Sections through the main bronchiole of the left
lobe were stained with H&E. (C) No abnormal lung histopathology was observed in mock-
challenged animals. (D) Wild type and (E) MyD88−/− influenza-challenged mice demonstrated
increased airway inflammation. (F) ASC−/− mice demonstrated significantly reduced
inflammation following influenza challenge. (G) Histological scoring of H&E stained lung
sections demonstrated a significant increase in inflammation following influenza challenge in
all mice. However, ASC−/− mice demonstrated a significant attenuation compared to
MyD88−/− and wild type animals (*p<0.05; **p<0.01). Wild type (n=8); MyD88−/− (n=7);
ASC−/− (n=6); wild type mock-infected (n=4). Results are representative of at least 2
independent experiments.
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Figure 2. The Nlrp3 inflammasome is required for survival and mediates airway inflammation and
viral clearance following pulmonary challenge with influenza virus
A Wild type, Nlrp3−/− and Nlrc4−/− mice were challenged i.n. with influenza A/PR/8/34 and
survival was monitored 14 dpi. Nlrp3−/− mice demonstrated significantly increased mortality
compared to wild type animals (**p<0.01; log rank). In contrast, loss of Nlrc4 did not have
any effect on mouse survival. Wild type mock-infected (n=7); wild type infected (n=19);
Nlrp3−/− infected (n=16); and Nlrc4−/− infected (n=7). All survival experiments were
performed together with the mice studied in Figure 1, therefore, the wild type controls are
identical to those shown in Figure 1. (B) Lungs from wild type, Nlrp3−/− and Nlrc4−/− mice
were harvested for histology and scored. A significant increase in airway inflammation was
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observed following influenza challenge in wild type and Nlrc4−/− animals, while a significant
attenuation was observed in Nlrp3−/− mice (*p<0.05; **p<0.01). (C) No abnormal lung
histopathology was observed in the mock-challenged wild type animals. (D) Nlrp3−/− mice
demonstrated significantly attenuated inflammation following influenza virus challenge. (E)
Nlrc4−/− and (F) wild type influenza challenged mice demonstrated increased airway
inflammation. (G) To profile the cell types involved in the host immune response to influenza
infection, bronchoalveolar lavage (BAL) was performed with differential staining and FACS
analysis, 3 dpi. Consistent with the histology data, significantly fewer total cells were recovered
in the BAL fluid (BALF) from Nlrp3−/− animals (*p<0.05), compared with either Nlrc4−/− or
wild type mice. (H) BALF cellularity indicated a significant influx of macrophages and
neutrophils in all influenza-challenged animals, with no difference observed in the composition
of cells present in the airways. Wild Type (n=8); Nlrp3−/− (n=5); Nlrc4−/− (n=3); ASC−/− (n=6);
wild type mock-infected (n=4). Results are representative of 3 independent experiments. (I)
While no differences were observed in BALF composition, differential staining revealed a
significant decrease in the total number of monocytes and neutrophils present in the Nlrp3−/−
mice (*p<0.05). Wild type (n=8); Nlrp3−/− (n=4); Nlrc4−/− (n=4); wild type mock-infected
(n=5). (J) Lungs were weighed and homogenized in sterile PBS either 3 or 7 dpi. Cell free
supernatants were titered by standard plaque assay. Nlrp3−/− mice demonstrated a significant
defect in vial clearance by day 7 (*p<0.05). Wild type mock-infected, d3 (n=3); wild type,
infected, d3 (n=9); Nlrp3−/− infected, d3 (n=9); wild type mock-infected d7 (n=4); wild type
infected, d7 (n=6); Nlrp3−/− infected, d7 (n=7).
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Figure 3. Nlrp3 inflammasome components are highly expressed in myeloid cells and in the lungs
during influenza A virus infection
(A–B) ASC and Nlrp3 gene expression was assessed in a panel of cells considered important
for viral infection. Primary mouse bone marrow derived macrophages (BM), B cells, T cells,
mouse airway epithelial cells (MAECs) and mouse embryonic fibroblasts (MEFs) were
assessed by real-time (rt) quantitative PCR with samples normalized to 18s and standardized
to expression in MEFs. Each cell line was assessed in triplicate and data are representative of
3 independent experiments. (C–D) Primary mouse BM s and MAECs were differentiated and
challenged with mouse adapted influenza A/PR/8/34 (MOI=10). Nlrp3, Nlrc4 and IL-1β
transcripts were assessed by rtPCR normalized to 18s and standardized to naive levels. (C) A
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significant increase in IL-1β mRNA expression was observed in BM following influenza
challenge (MOI=10); however, no significant change was observed in Nlrp3 or Nlrc4
expression (*p<0.05). (D) Influenza challenge (MOI=1) resulted in a significant increase in
Nlrp3 expression and a modest decrease in Nlrc4 and IL-1β expression in the MAECs. (E)
Whole lungs were removed from wild type mice either 3 dpi. or 7 dpi. and homogenized. Total
RNA was extracted from tissue pellets and expression levels of Nlrp3, ASC, Il-1β and
Caspase-1 (Casp1) were assessed by rtPCR normalized to the 18S house keeping gene and
compared to the mock-infected lungs. Transcription levels are significantly elevated by day 3
following influenza inoculation and begin to decline by day 7 (*p<0.05). All experiments are
representative of at least 2 independent experiments with 3–5 mice per group.
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Figure 4. Mice lacking components of the Nlrp3 Inflammasome demonstrate significantly altered
levels of proinflammatory cytokines following pulmonary challenge with influenza
Wild type, ASC−/−, Nlrp3−/− and Nlrc4−/− mice were challenged with influenza A/PR/8/34.
Serum and cell free BALF were assessed 3 dpi., unless otherwise noted. (A–B) Significantly
reduced levels of IL-1β(A) and IL-18 (B) were observed in the serum from Nlrp3−/− and
Asc−/− mice (*p<0.05). (C–F) Nlrp3−/− and ASC−/− mice also demonstrated significantly
reduced levels of BALF IL-1β (C) and MIP2α (D). KC was slightly decreased in Nlrp3−/− mice
(E), while TNFα was reduced in ASC−/− mice (F) (*p<0.05). BALF levels of IL-18 were below
the level of detection (data not shown). (G–I) All infected animals demonstrated a significant
increase in IL-6 (G), IFNγ(H) and IL-12p40 (I) with no differences observed between
genotypes. Mock, n=5; Nlrp3−/−, n=6; Nlrc4−/−, n=6; ASC−/−, n=9; Wild Type, n=5. (J) BALF
from moribund Nlrp3−/− mice demonstrate significantly increased local levels of IL-6
compared to moribund wild type animals, 7 dpi.(*p<0.05). Mock, n=3; Nlrp3−/−, n=6; wild
type, n=3. All data are representative of at least 2 independent experiments.
Allen et al. Page 19













Figure 5. NLRP3 inflammasome activation in response to influenza virus is dependent upon
lysosomal maturation and ROS production in human cells
(A) Depiction of the primary ciliated human airway epithelial (HAE) cultures which were
infected with the human pathogenic influenza virus A/Victoria/3/75 (H3N2; MOI = 1).
Supernatants are collected from the apical and basolateral surfaces. (B) Robust viral replication
was observed over the course of the HAE infection. (C) IL-1β levels were detected in the apical,
but not basolateral, compartment 48 hours post-infection. (D) Human nasal airway epithelial
cell lines (JME) were infected with A/Victoria/3/75 (MOI=1) and increased NLRP3 and
ASC mRNA expression was observed. Data was normalized to 18s and compared to the
expression in similarly treated human type II alveolar epithelial-like cell lines (A549). (E)
Increased IL-1β protein was observed 24 hours post-infection in the cell free supernatant from
the JMEs. (F) Human THP-1 monocyte cell lines were infected with A/Victoria/3/75 (MOI=5)
and increased IL-1β levels were observed in the supernatant over a 24hr time course. (G–I)
Influenza mediated IL-1β generation is dependent upon the NLRP3 inflammasome in human
monocytes. (G) Human THP-1 cells were infected with lentivirus containing shRNA for ASC,
NLRP3 or TUCAN (shASC, shNLRP3 or shTUCAN) or a mutated sh target sequence (shmut).
Cell free supernatants were collected 24 hours post-infection (MOI=1). Influenza induced
NLRP3- and ASC- dependent increase in IL-1β (*p<0.05), which was independent of TUCAN.
(H) The general caspase inhibitor ZVAD-CHO and (I) the caspase-1 specific inhibitor Ac-
YVAD-CHO, both inhibited IL-1β release in a dose-dependent manner (*p<0.05). (J–L)
Influenza mediated IL-1β maturation requires lysosomal maturation and ROS production in
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THP-1. IL-1β release during influenza infection (MOI=5) was attenuated following treatment
with (J) the lysosome inhibitor bafilomycin A (100–250nM), (K) the cathepsin B inhibitor
CA-074-Me (50μM), and (L) the ROS inhibitors APDC (100μM) and NAc (50μM)(*p<0.05).
(M) Treatment with the ROS inhibitor NAc (250mg/kg) inhibits influenza mediated IL-1β
release in vivo (*p<0.05). NAc Mock, n=1; NAc Influenza, n=5, Vehicle Influenza, n=3.
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Figure 6. The NLRP3 inflammasome is required for airway inflammation induced by nucleic acid
analogs
Wild type and Nlrp3−/− mice received either 2 doses (50μg/dose) of poly(I:C) or vehicle on
alternating days and were harvested 24hrs after the second dose was administered. (A–B) Poly
(I:C) challenged animals demonstrated increased airway inflammation but less inflammatory
cell influx was observed in Nlrp3−/− mice. (C) Histology scoring confirmed a significant
attenuation in airway inflammation in the Nlrp3−/− mice (*p<0.05). (D) Significant decreases
were observed in BALF IL-1β in the Nlrp3−/− mice compared to the wild type animals
(*p<0.05). Vehicle challenged wild type (n=4); wild type, n=8; Nlrp3−/−, n=8. (E–G) IL-1β
induction by viral RNA analogs in human monocytic cells is mediated by NLRP3 and ASC.
(E) IL-1β secretion stimulated by the viral dsRNA analog poly(I:C) was significantly reduced
in the shNLRP3 and shASC knockdown THP-1 cell lines and (F) following treatment with the
caspase-1 specific inhibitor yVAD-CHO (*p<0.05). (G) IL-1β secretion stimulated by
ssRNA40 was also significantly reduced in the shNLRP3 and shASC containing cells
(*p<0.05). All knockdown studies are representative of at least 3 independent experiments.
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(H–J) Poly(I:C) mediated IL-1β maturation requires lysosomal maturation and ROS
production in human monocytes. (H) The lysosome inhibitor bafilomycin A (100nM), (I) the
cathepsin B inhibitor CA-074-Me (50μM), and (J) the ROS inhibitors APDC (100μM) and
NAc (50μM) all significantly attenuated IL-1β production (*p<0.05).
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